Efficacy and Safety of 500mg of Fulvestrant | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of 500mg of Fulvestrant	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Active, not recruiting	Phase 2	2026-05-22		NCT00585507

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beth Israel Deaconess Medical Center	161
Brigham and Women's Hospital	378
Dana-Farber Cancer Institute	324
Lowell General Hospital	1
Massachusetts General Hospital	758
South Shore Hospital	2
University of Colorado, Denver	475
University of Maryland Greenebaum Cancer Center	2

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beth Israel Deaconess Medical Center	Boston	United States	45
Dana-Farber Cancer Institute	Boston	United States	68
Lowell General Hospital	Lowell	United States	47
Massachusetts General Hosptial	Boston	United States	1
South Shore Hospital	South Weymouth	United States	4